✦ LIBER ✦

Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?

✍ Scribed by Shinohara, Nobuo; Abe, Takashige; Mochizuki, Tango; Kashiwagi, Akira; Kanagawa, Kouichi; Maruyama, Satoru; Sazawa, Ataru; Oba, Koji; Nonomura, Katsuya

Book ID: 121229741
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 348 KB
Volume: 31
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2011.08.009

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement of prognosis in patients wit

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice

✍ Tomomi Kamba, Toshinari Yamasaki, Satoshi Teramukai, Noboru Shibasaki, Ryuichiro 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 434 KB

Validation and Extension of the Memorial

Validation and Extension of the Memorial Sloan-Kettering Prognostic Factors Model for Survival in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

✍ Mekhail, T. M. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 254 KB

Sunitinib in patients with metastatic re

Sunitinib in patients with metastatic renal cell carcinoma: Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY

✍ Michael L. Blute 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Prognostic factors for survival in previ

Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY.: J Clin Oncol 2004;22:454–63

✍ Donald L. Trump 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 21 KB

Effect of comorbidity on risk of venous

Effect of comorbidity on risk of venous thromboembolism in patients with renal cell carcinoma11The project described was supported by the National Center for Research Resources, United States, through Grant KL2TR000084 the National Center for Advancing Translational Sciences, United States, through Grant KL2TR000084 and the National Institutes of Health, United States, through Grant KL2TR000084, and a grant from the Danish Cancer Society (R73-A4284-13-S17) and from the Karen Elise Jensen Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and the Clinical Epidemiological Research Foundation.

✍ Smith, Angela B.; Horvath-Puhó, Erzsébet; Nielsen, Matthew E.; Lash, Timothy L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 220 KB